Skip to content
  1. Home
  2. >Clinical Genomics
  3. >Carrier Screening
  4. >Core Carrier Screen

HELIX DIAGNOSTICS

Core Carrier Screen

Test Description

The Helix Core Carrier Screen analyzes 39 genes associated with serious inherited conditions, aligned with ACMG Tier 2 guidelines and ACOG recommendations. This comprehensive panel covers conditions with a carrier frequency greater than 1 in 100.

Genes Tested (39)

Scroll down for more

ABCC8
ABCD1
ACADM
ALDOB
ASPA
ATP7B
BLM
CFTR
COL4A5
CPT2
DHCR7
DLD
DMD
ELP1
FANCC
FKTN
FMR1
GAA
GALC
GBA
GLA
HBA1
HBA2
HBB
HEXA
HOGA1
IDS
MCOLN1
MTM1
NR0B1
PAH
PKHD1
PMM2
RS1
SLC22A5
SLC26A4
SMN1
SMPD1
USH2A

Important Panel Information

Turnaround time: Typically 7 to 21 days

Preferred specimen: Oragene Dx Saliva Collection Kit

Shipping instructions: Specimens to arrive at Helix within 96 hours of collection at ambient temperature.

This panel includes genes that have an established association with inherited conditions that have a carrier frequency in the general population of at least 1 in 100 and/or the conditions associated are recommended to be part of carrier screening panels for specific ethnic groups by the American College of Obstetricians and Gynecologists (ACOG). The conditions on this panel are well understood in the literature, have clearly defined strong gene-disease associations, and have widely available prenatal diagnosis. The clinical impact of these conditions is classified as severe or profound by ACMG (life-threatening or life-shortening, with complex disease course requiring surgical and medical intervention, early onset).

All detected variants are evaluated according to American College of Medical Genetics and Genomics recommendations. Variants are classified based on known, predicted, or possible pathogenicity and reported with interpretive comments detailing their potential or known significance.

Other Tests to Consider

Fundamental Carrier Screen

2 genes

Comprehensive Carrier Screen

278 genes

Expanded Carrier Screen

115 genes